Pictet Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.23M Sell
78,400
-14,140
-15% -$1.2M 0.01% 774
2026
Q1
$7.96M Sell
92,540
-25,114
-21% -$2.25M 0.01% 699
2025
Q4
$10.3M Sell
117,654
-2,642
-2% -$201K 0.01% 672
2025
Q3
$6.88M Buy
120,296
+16,661
+16% +$959K 0.01% 747
2025
Q2
$6.11M Buy
103,635
+7,688
+8% +$497K 0.01% 751
2025
Q1
$7.02M Buy
95,947
+16,497
+21% +$1.36M 0.01% 740
2024
Q4
$6.57M Sell
79,450
-5,786
-7% -$456K 0.01% 760
2024
Q3
$6.1M Sell
85,236
-17,057
-17% -$1.2M 0.01% 768
2024
Q2
$7.01M Buy
102,293
+9,935
+11% +$594K 0.01% 716
2024
Q1
$4.95M Sell
92,358
-1,469
-2% -$79K 0.01% 784
2023
Q4
$5M Sell
93,827
-882
-0.9% -$43K 0.01% 791
2023
Q3
$4.7M Buy
+94,709
New +$5.3M 0.01% 786

Other funds holding GMED

Pictet Asset Management's GMED Position: Q2 2026 in Review

Pictet Asset Management reduced its Globus Medical (GMED) stake by 15% in Q2 2026, selling an estimated $1.2M and leaving 78,400 shares worth $6.23M. The position accounts for 0.01% of the portfolio, ranked #774.

Pictet Asset Management first reported a position in GMED in Q3 2023 and has held it in 12 quarters since. The position peaked at $10.3M in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Pictet Asset Management held 78,400 shares of Globus Medical worth $6.23M as of Q2 2026.
  • Pictet Asset Management sold 14,140 Globus Medical shares in Q2 2026, an estimated $1.2M.
  • Globus Medical made up 0.01% of Pictet Asset Management's portfolio in Q2 2026, its #774 holding.
  • Pictet Asset Management first reported a position in Globus Medical in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Globus Medical position peaked at $10.3M in Q4 2025.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.